英文名稱 | Capecitabine | RO 09-1978 | Xeloda |
---|---|
中文名稱 | 卡培他濱 |
CAS號 | 154361-50-9 |
分子式 | C15H22FN3O6 |
分子量 | 359.35 |
外觀 | White to off-white powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | Capecitabine | RO 09-1978 | Xeloda |
---|---|
中文名稱 | 卡培他濱 |
CAS號 | 154361-50-9 |
分子式 | C15H22FN3O6 |
分子量 | 359.35 |
外觀 | White to off-white powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Capecitabine is a fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites. As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells. FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate for incorporation into the RNA strand.
https://doi.org/10.1016/j.clinthera.2005.01.005
PMID: 18077151 DOI: 10.1016/j.ejca.2007.10.023